48,830
edits
Difference between revisions of "Salivary duct carcinoma"
Jump to navigation
Jump to search
Salivary duct carcinoma (view source)
Revision as of 02:17, 18 January 2016
, 02:17, 18 January 2016no edit summary
(wikify) |
|||
| Line 80: | Line 80: | ||
Curiosity: | Curiosity: | ||
*PSA +ve/-ve. | *[[PSA]] +ve/-ve. | ||
*PSAP +ve/-ve. | *[[PSAP]] +ve/-ve. | ||
*ER-beta +ve.<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf]. Accessed on: 3 April 2012.</ref> | *ER-beta +ve.<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf]. Accessed on: 3 April 2012.</ref> | ||
*ER-alpha -ve (the common ''ER'' stain). | *ER-alpha -ve (the common ''ER'' stain). | ||